Merck MRK
NYSE MRK
$145.81 -3.47 (-2.32%)
As of: Sep 30, 2026 · 3:41 PM EDT

Merck (MRK) Operating Income (2009 - 2026)

Updated

Merck's Operating Income came in at -$584 million for Q2 2026, compared with $4.99 billion a year earlier.

Analysis

Merck (MRK) Operating Income (2009 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Merck reported Operating Income of $6.38 billion, down 66.6% year-over-year; for FY2025, it was $21.22 billion, up 6.6% from FY2024.

  • Operating Income carries a five-year compound annual growth rate of 33.7% (FY2020 to FY2025).
  • Going back by year, Operating Income was $19.91 billion in FY2024 (-27.3%), $27.39 billion in FY2023 (+52.6%), $17.95 billion in FY2022 (+43.1%) and $12.54 billion in FY2021 (+152.1%).
  • The five-year range for quarterly Operating Income is -$5.16 billion (Q2 2023) to $6.51 billion (Q3 2025).
  • Year-over-year, Operating Income increased in three of the last six quarters, with growth averaging 18.2%.
  • The fastest year-over-year change in Operating Income over five years came in Q2 2022 (growth of 205.1%), and the weakest in Q4 2023 (a decline of 37.2%).
  • Business Quant data shows MRK's Operating Income at -$3.4 billion (Q1 2026), $3.85 billion (Q4 2025) and $6.51 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Op. Inc (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 7.14 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 6.43 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn -584.00 Mn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 4.75 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 3.16 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 3.51 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn -10.39 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 4.27 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 1.25 Bn
10 Bristol Myers Squibb 128.45 Bn 79.72 Bn 9.25 Bn 360.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -584.00 Mn
Mar 31, 2026 -3.40 Bn
Dec 31, 2025 3.85 Bn
Sep 30, 2025 6.51 Bn
Jun 30, 2025 4.99 Bn
Mar 31, 2025 5.87 Bn
Dec 31, 2024 4.30 Bn
Sep 30, 2024 3.93 Bn
Jun 30, 2024 6.05 Bn
Mar 31, 2024 5.64 Bn
Dec 31, 2023 2.16 Bn
Sep 30, 2023 5.75 Bn
Jun 30, 2023 -5.16 Bn
Mar 31, 2023 3.74 Bn
Dec 31, 2022 3.44 Bn
Sep 30, 2022 4.01 Bn
Jun 30, 2022 4.93 Bn
Mar 31, 2022 5.57 Bn
Dec 31, 2021 3.58 Bn
Sep 30, 2021 4.82 Bn
API Access

Merck Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-income&ticker=MRK&period=max&api_key=YOUR_API_KEY